Inventor · disambiguated record
Stewart Chipman
Also filed as: CHIPMAN STEWART · CHIPMAN STEWART D
9 granted patents·6 pending applications·121 citations·filing 1995–2024
87Inventor score
Top patents by PatentIndex Score
15 records- 0194US8129348B2Conjugates of biologically active proteins having a modified in vivo half-lifeBESMAN MARC·Filed 2008·Granted Mar 6, 2012·55 cites·9 claims
- 0293US10722591B2Cleavable conjugates of TLR7/8 agonist compounds, methods for preparation, and uses thereofDYNAVAX TECH CORP·Filed 2018·Granted Jul 28, 2020·7 cites·121 claims
- 0389US10618896B2Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereofDYNAVAX TECH CORP·Filed 2018·Granted Apr 14, 2020·4 cites·15 claims
- 0481US11124510B2Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereofDYNAVAX TECH CORP·Filed 2020·Granted Sep 21, 2021·1 cites·21 claims
- 0579US2024368155A1Alkyl chain modified imidazoquinoline tlr7/8 agonist compounds and uses thereofDYNAVAX TECH CORP·Filed 2024·Application pending·0 cites
- 0675US6452050B1Synthesis and use of α-ketoamide derivatives and arraysARQULE INC·Filed 2000·Granted Sep 17, 2002·7 cites·11 claims
- 0773US11981670B2Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereofDYNAVAX TECH CORP·Filed 2021·Granted May 14, 2024·0 cites·30 claims
- 0871US5591740AUse of debromohymenialdisine for treating osteoarthritisOSTEOARTHRITIS SCIENCES INC·Filed 1995·Granted Jan 7, 1997·35 cites·12 claims
- 0970US6143931ASynthesis and use of α-ketoamide derivatives and arraysARQULE INC·Filed 1998·Granted Nov 7, 2000·12 cites·24 claims
- 1057US8748577B2Conjugates of biologically active polypeptides having an increased in vivo half-lifeBESMAN MARC·Filed 2012·Granted Jun 10, 2014·0 cites·8 claims
- 1149US2005281824A1Methods of using IMXP-888 and IMXP-888 antagonistsIMMUNEX CORP·Filed 2005·Application pending·0 cites
- 1245US2002136720A1Methods of using IMXP-888 and IMXP-888 antagonistsFiled 2001·Application pending·0 cites
- 1342US2006089414A1Generic probes for the detection of phosphorylated sequencesMORGENSTERN KURT A·Filed 2005·Application pending·0 cites
- 1441US2016296632A1Engineered glycoproteins and uses thereofAEQUUS BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 1537US2017326232A1Intratumoral administration of particles containing a toll-like receptor 9 agonist and a tumor antigen for treating cancerDYNAVAX TECH CORP·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →